Objective
Depression is one of the most common symptoms in patients with multiple sclerosis (MS) with a prevalence of up to 50%. Depression is linked to decreased cognitive function, lower quality of life, increases psychosocial and economic burden and is the strongest predictor of suicide.
Despite the high clinical relevance, the pathogenetic substrates for depression in MS are poorly understood. Growing evidence suggests that it may be largely biologically mediated by some of the same processes involved in the immunopathogenesis of this neurologic disease. In particular, increases in proinflammatory cytokines, and activation of the hypothalamic-pituitary-adrenal (HPA) axis have independently been shown to be involved in major depressive disorder (MDD) as well as MS.
Pregnancy is associated with profound changes in the endocrine and immune system and interestingly, the post partum period is characterized by a higher risk for relapses both in depression and MS. During pregnancy, in contrast, there is an approximately 80% reduction in MS relapse rate, an effect that is stronger than that achieved by any of the currently approved disease-modifying therapies. Thus, pregnancy is a powerful paradigm to study shared mechanisms of disease activity in MS and depression.
In the proposed study, we will determine immunological and endocrine correlates of mood changes longitudinally in female relapsing-remitting MS patients during pregnancy and post partum. Clinical interviews and validated questionnaires will be used to examine depression incidence and severity. Blood samples for immune studies, salivary cortisol levels, and measures of depressive symptomatology and cognitive function will be obtained during the 2nd trimester, 3rd trimester, and 3 months post partum. This study will enable us to better understand immune-endocrine mechanisms of depression as well as disease activity in MS. This could have important implications for developing better therapeutic approaches.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences neurobiology cognitive neuroscience
- medical and health sciences basic medicine neurology multiple sclerosis
- medical and health sciences basic medicine immunology
- medical and health sciences clinical medicine obstetrics
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2010-RG
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
20251 Hamburg
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.